Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation (Q80978609)
Jump to navigation
Jump to search
scientific article published on 31 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation |
scientific article published on 31 August 2007 |
Statements
Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation (English)
Khanolkar MP
Morris RH
Thomas AW
Bolusani H
Roberts AW
Geen J
Jackson SK